GeneDx Holdings Corp (NASDAQ: WGS) is 638.91% higher on its value in year-to-date trading and has touched a low of $1.16 and a high of $21.71 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The WGS stock was last observed hovering at around $19.27 in the last trading session, with the day’s gains setting it 1.05%.
Currently trading at $20.32, the stock is 49.74% and 84.36% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.52 million and changing 5.45% at the moment leaves the stock 267.12% off its SMA200. WGS registered 143.35% gain for a year compared to 6-month gain of 1194.27%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 75.78% loss in the last 1 month and extending the period to 3 months gives it a 425.06%, and is 4.21% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.96% over the week and 12.03% over the month.
GeneDx Holdings Corp (WGS) has around 1000 employees, a market worth around $531.37M and $221.85M in sales. Profit margin for the company is -60.86%. Distance from 52-week low is 1651.72% and -6.40% from its 52-week high. The company has generated returns on investments over the last 12 months (-41.99%).
The EPS is expected to grow by 65.21% this year
The shares outstanding are 25.98M, and float is at 16.27M with Short Float at 6.57%.
GeneDx Holdings Corp (WGS) Insider Activity
The most recent transaction is an insider sale by Stueland Katherine, the company’s Chief Executive Officer. SEC filings show that Stueland Katherine sold 6,325 shares of the company’s common stock on Apr 29 ’24 at a price of $11.04 per share for a total of $69808.0. Following the sale, the insider now owns 75869.0 shares.
GeneDx Holdings Corp disclosed in a document filed with the SEC on Apr 29 ’24 that Feeley Kevin (CHIEF FINANCIAL OFFICER) sold a total of 1,104 shares of the company’s common stock. The trade occurred on Apr 29 ’24 and was made at $11.04 per share for $12185.0. Following the transaction, the insider now directly holds 30836.0 shares of the WGS stock.
Still, SEC filings show that on Mar 18 ’24, Stueland Katherine (CHIEF EXECUTIVE OFFICER) disposed off 8,559 shares at an average price of $10.59 for $90661.0. The insider now directly holds 66,698 shares of GeneDx Holdings Corp (WGS).
